phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with lysine in 1 studies
| Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 191 | 4 | 23 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | phenylalanyl-prolyl-arginine-chloromethyl ketone (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajzar, L; Fredenburgh, JC; Rischke, JA; Stewart, RJ; Weitz, JI | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and lysine
| Article | Year |
|---|---|
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen
Topics: Amino Acid Chloromethyl Ketones; Arginine; Carboxypeptidase B; Carboxypeptidase B2; Carboxypeptidases; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Humans; Kinetics; Lysine; Models, Chemical; Tissue Plasminogen Activator | 2000 |